-
KalVista Pharmaceuticals Announces FDA Approval of EKTERLY® (sebetralstat), First and Only Oral On-demand Treatment for Hereditary Angioedema
07 Jul 2025 10:34 GMT
… 3 trial. “Until now, on-demand treatment relied … itraconazole, phenytoin, efavirenz.
Know the medicines you take. Keep … Food and Drug Administration (FDA) directly. Visit www.fda.gov… .
About KalVista Pharmaceuticals, Inc.
KalVista Pharmaceuticals, Inc., is …
-
Exploring Adherence, Treatment Experiences, and Quality of Healthcare Services in HIV Management Among Iraqi Patients: Challenges and Influential Factors
19 Jul 2025 11:23 GMT
… with HIV: treatment of HIV, Adherence to prescribed anti-HIV medications, and … a combination of three drugs: tenofovir disoproxil, lamivudine … disorders in the Iraqi pharmaceutical market. PLoS One. … efavirenz in HIV study participants in Mbeya, Tanzania. AIDS …
-
Spectrum and Correlates of Dyslipidemia in People Living with HIV on Dolutegravir-Based Regimen Attending Kabutare Hospital, Southern Rwanda: A Cross-Sectional Study
15 Jul 2025 21:37 GMT
… medical records to extract HIV-related clinical information such as treatment … cardiovascular risk in clinical trials.42 However, real- … profile after switching from efavirenz or ritonavir-boosted protease … the ANRS 12136 temprano trial. AIDS Res Ther. 2016;13 …
-
“Radical Transparency” or Not? FDA Releases Hundreds of Decision Letters to the Public
11 Jul 2025 14:03 GMT
… transparency”, the US Food and Drug Administration (FDA) has made over 200 … of bringing cures and meaningful treatments to patients faster.”
The agency … CRL addressed to AB pharmaceuticals for the product efavirenz, lamivudine and tenofovir …
-
Antiretroviral drugs in South Africa’s rivers raise environmental concerns
10 Jul 2025 19:25 GMT
… attributed to South Africa’s HIV treatment programme, the most extensive of … to 90% of orally consumed pharmaceutical drugs reach wastewater in one form … , lopinavir, efavirenz, zidovudine) and the antifungal fluconazole. Although most pharmaceuticals are not …
-
Merck to Present New Data Highlighting Research Advancements Across its HIV Prevention and Treatment Pipeline at IAS 2025
08 Jul 2025 10:53 GMT
… trials evaluating the safety and tolerability of weekly ulonivirine and drug … medications for the treatment of HIV- … 1 infection is not recommended.
Coadministration of PIFELTRO with efavirenz … impact of pharmaceutical industry regulation …
-
PREPARE Trial: Over Half of Middle-Aged Adults With HIV Experience Physical Function Decline
07 Jul 2025 15:55 GMT
… included history of depression treatment, elevated body mass index … or contribute to neuropathy. Efavirenz has also been linked … side effects or drug interactions with HIV medications that might … protease inhibitors with some statins.
Reference
Kulik GL, …
-
Corcept Presents Data from Treatment Phase of CATALYST Trial at American Diabetes Association’s 85th Scientific Sessions with Simultaneous Publication in Diabetes Care
23 Jun 2025 20:49 GMT
… to enter the trial’s treatment phase, where … caution with bupropion and efavirenz.
Hormonal contraceptives: Do … is conducting advanced clinical trials in patients with … medication approved by the U.S. Food and Drug Administration for the treatment …
-
Corcept Presents Data from Treatment Phase of CATALYST Trial at American Diabetes Association’s 85th Scientific Sessions with Simultaneous Publication in Diabetes Care
23 Jun 2025 20:45 GMT
… to enter the trial’s treatment phase, where … caution with bupropion and efavirenz.
Hormonal contraceptives: Do … is conducting advanced clinical trials in patients with … medication approved by the U.S. Food and Drug Administration for the treatment …
-
Opinion: The decades-long journey to Gilead’s twice-a-year HIV prevention drug lenacapavir
23 Jun 2025 14:34 GMT
… unmet need in the treatment of HIV and AIDS.
Tomas Cihlar got … and a small Californian biotech start-up called Gilead … to guide drug hunters towards viable small molecule medicines, but Link … a greater impact in the pharmaceutical industry. Her more than …
About
© 1995-2025